Caster Semenya of South Africa lead the group in the women senior 1500m final during the 2016 CAA 20th African Senior Championships at the Kings Park Athletic stadium in Durban, South Africa on June 24, 2016
Caster Semenya of South Africa, the 2016 Rio Olympics 800m Champion has been found to be at 1.8 per cent advantage in 800m by the IAAF in the new study conducted by IAAF in conjuction with the World Anti-Doping Agency {WADA} and published by British Journal of Sports Medicine. In the main report which analysed more than 2,100 androgen samples from athletes participating at the 2011 and 2013 World Championship. The report which was published by the IAAF on the 3rd of July, 2017; proved the unfair advantage of high level of testosterone in a female athlete body system.
In the 400m the advantage is 2.7 per cent, 400m hurdle-2.8 per cent advantage, 800m-1.8 per cent, hammer-4.5 per cent advantage and in Pole Vault-2.9 per cent advantage.
Caster and other athletes with higher testosterone has been taken medication to lower it until 2015 when Court of Arbitration For Sport {CAS} suspended the rule which normally enforced a limit on female athletes’s naturally occuring testosterone level. The IAAF was given 2 years to respond to that decision. So with this latest result now, the enforced lowering medication will resume. Stephane Bermon, one of the study authors, said, ”our starting position is to defend, pretect and promote fair female competition”.
DiscernSport